Amag Pharmaceuticals (AMAG) Stock Analyst Ratings
NASDAQ:AMAG - Nasdaq -
ChartMill assigns a Buy % Consensus number of 60% to AMAG. The Buy consensus is the weighted average rating of the current analysts ratings.
AMAG was analyzed by 7 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about AMAG.
In the previous month the buy percentage consensus was at a similar level.
AMAG was analyzed by 7 analysts. More opinions would make the average more meaningful.